Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination (NCT06007183)
A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (CHIKV VLP) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in adult and adolescent participants and to evaluate CHIKV VLP booster vaccine induced serum neutralizing antibody (SNA) response at 3 or 4 years post-initial CHIKV VLP vaccination.
Who can join: Review the eligibility criteria below.
Location: Alliance for Multispecialty Research, LLC — Mobile, Alabama
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (24 Sites)
- Alliance for Multispecialty Research, LLC — Mobile, Alabama
- Alliance for Multispecialty Research, LLC — Tempe, Arizona
- Optimal Research, LLC — Melbourne, Florida
- Suncoast Research Associates, LLC — Miami, Florida
- Synexus Clinical Research US, Inc. — Chicago, Illinois
- Optimal Research, LLC — Peoria, Illinois
- Alliance for Multispecialty Research, LLC — Newton, Kansas
- Alliance for Multispecialty Research, LLC — Wichita, Kansas
- Alliance for Multispecialty Research, LLC — Lexington, Kentucky
- Alliance for Multispecialty Research, LLC — Kansas City, Missouri
- Wr-Crcn, Llc — Las Vegas, Nevada
- Alliance for Multispecialty Research, LLC — Las Vegas, Nevada
- Rochester Clinical Research, LLC — Rochester, New York
- M3 Wake Research Inc. — Raleigh, North Carolina
- Velocity Clinical Research, Cleveland — Cleveland, Ohio
- Lynn Institute of Norman — Norman, Oklahoma
- Velocity Clinical Research, Medford — Medford, Oregon
- Velocity Clinical Research, Providence — East Greenwich, Rhode Island
- Velocity Clinical Research, Austin — Cedar Park, Texas
- DM Clinical Research — Houston, Texas
- BFHC Research, LLC — San Antonio, Texas
- DM Clinical Research — Tomball, Texas
- Velocity Clinical Research, Salt Lake City — West Jordan, Utah
- Alliance for Multispecialty Research, LLC — Norfolk, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chikungunya Virus Infection
Explore by condition: All Chikungunya Virus Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.